Sep 23, 2026 8 0
Uploaded by Bulrr
Favorite
Share
More Options
8
Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune-Related Adverse Events in Patients With Bladder Cancer_Page 1

Open in WPS to view all 8 pages